|

human umbilical cord mesenchymal stem cells Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 1

Top Sponsors

  • Shanghai IxCell Biotechnology Co., LTD1
  • Shanghai Changzheng Hospital1

Indications

  • Knee Osteoarthritis1
  • Arthritis1
  • Diabetes1

Other2 trials

Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis
Phase 3
UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.